Valuation : Alcon Inc.

Market Cap 33.36B 170B 28.69B 26.99B 24.63B 45.97B 3,163B 46.2B 320B 124B 1,617B 125B 123B 5,122B P/E 2026 *
38.8x
P/E 2027 * 24.6x
Enterprise Value 35.9B 183B 30.88B 29.05B 26.51B 49.48B 3,404B 49.73B 344B 133B 1,740B 135B 132B 5,513B EV / Sales 2026 *
3.24x
EV / Sales 2027 * 2.96x
Free-Float
97.34%
Yield 2026 *
0.54%
Yield 2027 * 0.6%
1 day+6.98%
1 month+6.98%
3 months+12.19%
6 months-7.95%
Current year-15.56%
1 month 38
Extreme 38
38
Current year 30.88
Extreme 30.88
43.96
1 year 30.88
Extreme 30.88
45
3 years 30.88
Extreme 30.88
56.76
5 years 30.35
Extreme 30.35
56.76
10 years 30.35
Extreme 30.35
56.76
Manager TitleAgeSince
Chief Executive Officer 60 30/06/2018
Director of Finance/CFO 58 07/04/2019
Chief Tech/Sci/R&D Officer - 31/12/2024
Director TitleAgeSince
Director/Board Member 60 -
Chairman 70 30/06/2018
Director/Board Member 63 31/01/2019
Change 5-day change 1-year change 3-year change Capi.($)
+6.98%-.--% - - 34.04B
+0.71%-6.70%-42.37%-13.71% 79.39B
-2.00%-4.68%-12.89%-24.38% 34.04B
-2.73%-3.42%-0.59%-23.46% 13.57B
+1.13%+5.03% - - 12.65B
+2.57%-1.92%-4.73%+625.95% 2.64B
+0.64%-0.36%-38.44%-57.43% 1.46B
-0.07%+10.80% - - 968M
-0.92%-5.88%+16.41%+1.48% 924M
-0.88%-1.84%-36.50%-20.69% 887M
Average +0.54%-1.27%-17.02%+69.68% 16.28B
Weighted average by Cap. +1.16%-4.56%-29.32%-5.14%

Financials

2026 *2027 *
Net sales 11.09B 56.41B 9.54B 8.97B 8.19B 15.28B 1,051B 15.36B 106B 41.1B 537B 41.64B 40.73B 1,703B 11.77B 59.89B 10.13B 9.53B 8.69B 16.23B 1,116B 16.31B 113B 43.64B 571B 44.21B 43.24B 1,808B
Net income 764M 3.89B 657M 618M 564M 1.05B 72.45B 1.06B 7.32B 2.83B 37.04B 2.87B 2.81B 117B 1.26B 6.4B 1.08B 1.02B 930M 1.74B 119B 1.74B 12.07B 4.67B 61.01B 4.73B 4.62B 193B
Net Debt 2.54B 12.94B 2.19B 2.06B 1.88B 3.51B 241B 3.52B 24.39B 9.43B 123B 9.56B 9.35B 391B 1.45B 7.38B 1.25B 1.17B 1.07B 2B 137B 2.01B 13.9B 5.37B 70.27B 5.44B 5.33B 223B
Logo Alcon Inc.
Alcon Inc. is the global leader in the design, manufacture and marketing of ophthalmic care products. Net sales break down by category of products as follows: - ophthalmic surgical products and equipment (55.7%): consumables (52.7% of net sales), implantable products (31%) and other products (16.3%; in particular surgical equipment) for the treatment of cataracts, retinal diseases, glaucoma and refractive errors; - vision care products (44.3%): contact lenses (60.6% of sales) and eye care products (39.4%; eye drops and ophthalmic ointments, etc.). At the end of 2025, the group operated 17 production sites worldwide. Net sales are distributed geographically as follows: Switzerland (0.7%), the United States (45.1%), Japan (5.9%), China (5.5%), and Other (42.8%).
Employees
25,000
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
26
Last Close Price
69.01USD
Average target price
91.40USD
Spread / Average Target
+32.45%

Quarterly revenue - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!